Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
153
-
Total 13F shares, excl. options
-
29M
-
Shares change
-
+4.07M
-
Total reported value, excl. options
-
$418M
-
Value change
-
+$66.4M
-
Put/Call ratio
-
1.32
-
Number of buys
-
110
-
Number of sells
-
-46
-
Price
-
$14.41
Significant Holders of Niagen Bioscience, Inc. - COM NEW (NAGE) as of Q2 2025
184 filings reported holding NAGE - Niagen Bioscience, Inc. - COM NEW as of Q2 2025.
Niagen Bioscience, Inc. - COM NEW (NAGE) has 153 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (3.92M shares), BlackRock, Inc. (3.86M shares), D. E. Shaw & Co., Inc. (1.6M shares), Tieton Capital Management, LLC (1.58M shares), GEODE CAPITAL MANAGEMENT, LLC (1.3M shares), ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (1.12M shares), STATE STREET CORP (1.02M shares), Nuveen, LLC (905K shares), Connor, Clark & Lunn Investment Management Ltd. (823K shares), and Qube Research & Technologies Ltd (673K shares).
This table shows the top 153 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.